
During the last three months, 9 analysts shared their evaluations of Nurix Therapeutics (NASDAQ:NRIX), revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.